These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20649919)

  • 1. Including the very elderly in clinical trials.
    White SM
    Anaesthesia; 2010 Aug; 65(8):778-80. PubMed ID: 20649919
    [No Abstract]   [Full Text] [Related]  

  • 2. Consecutive screening and enrollment on clinical trials.
    Bjørn M; Brendstrup C; Karlsen S; Carlsen JE
    J Card Fail; 1999 Sep; 5(3):283-4. PubMed ID: 10496202
    [No Abstract]   [Full Text] [Related]  

  • 3. Supporting patient screening to identify suitable clinical trials.
    Bucur A; Van Leeuwen J; Chen NZ; Claerhout B; De Schepper K; Perez-Rey D; Alonso-Calvo R; Pugliano L; Saini K
    Stud Health Technol Inform; 2014; 205():823-7. PubMed ID: 25160302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consecutive screening and enrollment in clinical trials.
    Julian D
    J Card Fail; 1998 Sep; 4(3):233. PubMed ID: 9754594
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies for patient recruitment into clinical trials.
    Yusuf S
    J Card Fail; 1998 Sep; 4(3):235-6. PubMed ID: 9754595
    [No Abstract]   [Full Text] [Related]  

  • 6. Conformity between protocol eligibility criteria for electronic patient identification: a comparison of clinical trials.
    Kamauu A; Agbor S; Kamauu A
    Stud Health Technol Inform; 2013; 192():1167. PubMed ID: 23920941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis.
    Sokka T; Pincus T
    Arthritis Rheum; 2003 Feb; 48(2):313-8. PubMed ID: 12571838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
    Plaue GM
    J Contemp Health Law Policy; 2000; 16(2):305-54. PubMed ID: 10921232
    [No Abstract]   [Full Text] [Related]  

  • 10. [Age 70 and older a criterion for inclusion - not exclusion].
    Glaeske G
    Urologe A; 2015 Dec; 54(12):1739-46. PubMed ID: 26582378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of eligibility criteria from ClinicalTrials.gov.
    Doods J; Dugas M; Fritz F
    Stud Health Technol Inform; 2014; 205():853-7. PubMed ID: 25160308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity versus generalizability in clinical trial design and conduct.
    Hennekens CH; Buring JE
    J Card Fail; 1998 Sep; 4(3):239-41. PubMed ID: 9754597
    [No Abstract]   [Full Text] [Related]  

  • 13. Rethinking trial eligibility in the NCD era.
    Lancet Oncol; 2015 Mar; 16(3):233. PubMed ID: 25752544
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection of patients for clinical trials: an interactive web-based system.
    Fink E; Kokku PK; Nikiforou S; Hall LO; Goldgof DB; Krischer JP
    Artif Intell Med; 2004 Jul; 31(3):241-54. PubMed ID: 15302090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer.
    Hotta K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    Lung Cancer; 2004 Oct; 46(1):61-76. PubMed ID: 15364134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion for protocol eligibility.
    Callum JL; Henry B; Lin Y
    N Engl J Med; 2010 Oct; 363(17):1681-2. PubMed ID: 20961259
    [No Abstract]   [Full Text] [Related]  

  • 17. A critical need to reconsider cancer trial eligibility requirements.
    Markman M
    Oncology; 2010; 79(1-2):1-2. PubMed ID: 21051911
    [No Abstract]   [Full Text] [Related]  

  • 18. Never too old? Age should not be a barrier to enrollment in cancer clinical trials.
    Aapro MS; Köhne CH; Cohen HJ; Extermann M
    Oncologist; 2005 Mar; 10(3):198-204. PubMed ID: 15793223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements for a patient recruitment system.
    Schreiweis B; Bergh B
    Stud Health Technol Inform; 2015; 210():521-5. PubMed ID: 25991202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center.
    Beck JT; Rammage M; Jackson GP; Preininger AM; Dankwa-Mullan I; Roebuck MC; Torres A; Holtzen H; Coverdill SE; Williamson MP; Chau Q; Rhee K; Vinegra M
    JCO Clin Cancer Inform; 2020 Jan; 4():50-59. PubMed ID: 31977254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.